What Happened?
Scarsdale, NY-based Sapience Therapeutics Appointed Barry Kappel as Chief Executive Officer
About the Company
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme (GBM), which is the most severe and deadly form of brain cancer.
About the Person
Barry Kappel is Chief Executive Officer at Sapience Therapeutics. Previously, Barry held various senior HR leadership roles in the industry.
Info Source
News
Short Profile